Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tabletsU.S. losartan ...
Scienture launches Arbli, the first FDA-approved liquid losartan, expanding hypertension treatment access across US ...
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...
Stocktwits on MSN
Why Is Scienture Stock Rising Today?
Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation. ・The U.S. losartan ...
COMMACK, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value ...
BEDMINSTER, N.J.--(BUSINESS WIRE)--Nautilus Neurosciences, Inc. has completed a transaction for the sale of the U.S. and Canadian rights to CAMBIA® (diclofenac potassium for oral solution) to Depomed, ...
Radiation fears from the shutdown of nuclear reactors in earthquake ravaged Japan has caused a run on potassium iodide and raised questions about the health effects of taking the substance. It also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results